Viewing Study NCT01865812


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-03-09 @ 4:22 AM
Study NCT ID: NCT01865812
Status: COMPLETED
Last Update Posted: 2022-08-24
First Post: 2013-05-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis
Sponsor: Intercept Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-12-03
Start Date Type: ACTUAL
Primary Completion Date: 2014-08-13
Primary Completion Date Type: ACTUAL
Completion Date: 2016-09-12
Completion Date Type: ACTUAL
First Submit Date: 2013-05-23
First Submit QC Date: None
Study First Post Date: 2013-05-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-08-25
Results First Submit QC Date: None
Results First Post Date: 2016-10-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-29
Last Update Post Date: 2022-08-24
Last Update Post Date Type: ACTUAL